LPL Financial LLC

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 1403438 FORT MILL, SC

Position in RCKT

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$558,787

+$227,949 QoQ

Shares Held

156,086

+65.6% QoQ

Ownership

0.143%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

LPL Financial LLC holds $467,195,563 across 201 Biotechnology names. RCKT ranks #73 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	268,062	$119,700,405
2	REGN	Regeneron Pharmaceuticals, Inc.	63,987	$49,438,915
3	INSM	INSMED Inc	138,281	$22,611,709
4	ALNY	Alnylam Pharmaceuticals, Inc.	67,637	$22,379,054
5	EXEL	Exelixis, Inc.	399,612	$17,139,358
6	ARGX	Argenx SE	23,247	$16,976,121
7	HALO	Halozyme Therapeutics, Inc.	194,304	$12,557,867
8	ROIV	Roivant Sciences Ltd.	378,656	$10,488,771

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$558,787	156,086	+65.6%	Shares	Sole	2026-05-06
2025-12-31	$330,838	94,256	+628.6%	Shares	Sole	2026-02-11
2025-09-30	$42,171	12,936	+15.6%	Shares	Sole	2025-11-12
2025-06-30	$27,405	11,186	-23.2%	Shares	Sole	2025-08-12
2025-03-31	$97,168	14,568	+41.5%	Shares	Sole	2025-05-07
2024-12-31	$129,383	10,293	-1.0%	Shares	Sole	2025-02-11
2024-09-30	$191,958	10,393	-0.8%	Shares	Sole	2024-11-08
2024-06-30	$225,612	10,479	+14.1%	Shares	Sole	2024-08-07
2024-03-31	$247,363	9,182	-10.3%	Shares	Sole	2024-05-10
2023-12-31	$306,653	10,232	-5.0%	Shares	Sole	2024-02-14
2023-09-30	$220,595	10,766	-9.8%	Shares	Sole	2023-11-13
2023-06-30	$237,267	11,941	-9.8%	Shares	Sole	2023-07-31
2023-03-31	$226,818	13,241	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.